NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,113 filers reported holding NOVARTIS A G in Q2 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $189,969 | +6.2% | 1,865 | +5.2% | 0.02% | 0.0% |
| Q2 2023 | $178,813 | +2.6% | 1,772 | -6.5% | 0.02% | -3.8% |
| Q1 2023 | $174,340 | +1.4% | 1,895 | 0.0% | 0.03% | -3.7% |
| Q4 2022 | $171,914 | +16.9% | 1,895 | -2.1% | 0.03% | +12.5% |
| Q3 2022 | $147,000 | -10.4% | 1,935 | 0.0% | 0.02% | -7.7% |
| Q2 2022 | $164,000 | -3.5% | 1,935 | 0.0% | 0.03% | +13.0% |
| Q1 2022 | $170,000 | +6.9% | 1,935 | +6.7% | 0.02% | +15.0% |
| Q4 2021 | $159,000 | +7.4% | 1,813 | 0.0% | 0.02% | 0.0% |
| Q3 2021 | $148,000 | -10.3% | 1,813 | 0.0% | 0.02% | -9.1% |
| Q2 2021 | $165,000 | +11.5% | 1,813 | +4.5% | 0.02% | 0.0% |
| Q1 2021 | $148,000 | -23.3% | 1,735 | -15.3% | 0.02% | -29.0% |
| Q4 2020 | $193,000 | +2.1% | 2,049 | -6.0% | 0.03% | -13.9% |
| Q3 2020 | $189,000 | -19.6% | 2,179 | -19.2% | 0.04% | -28.0% |
| Q2 2020 | $235,000 | +8.8% | 2,696 | +3.0% | 0.05% | -13.8% |
| Q1 2020 | $216,000 | -12.6% | 2,618 | +0.5% | 0.06% | +1.8% |
| Q4 2019 | $247,000 | – | 2,604 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |